| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $14.8M | -16.1% |
| SG&A Expense | $15.3M | +30.1% |
| Operating Income | -$36.7M | -10.3% |
| Pre-tax Income | -$32.0M | +3.3% |
| Income Tax | $576K | +0.0% |
| Net Income | -$32.5M | +3.3% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.5M | -36.5% |
| Current Assets | $34.4M | -22.9% |
| Total Assets | $103.6M | -9.1% |
| Current Liabilities | $5.8M | +27.6% |
| Total Liabilities | $12.2M | +15.2% |
| Stockholders' Equity | $90.8M | -11.7% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.1M | -2.5% |
| Financing Cash Flow | $13.8M | — |